News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Antoun Houranieh, PhD

Articles by Antoun Houranieh, PhD

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts

ByAmy J. Grizzle, PharmD,Maysaa H. Mahmood, MS,Yu Ko, MS,John E. Murphy, PharmD,Edward P. Armstrong, PharmD,Grant H. Skrepnek, PhD,William N. Jones, MS,Gregory P. Schepers, PharmD,W. Paul Nichol, MD,Antoun Houranieh, PhD,Donna C. Dare, PharmD,Christopher T. Hoey, PharmD,Daniel C. Malone, PhD

October 1st 2007

Latest Updated Articles

Reasons Provided by Prescribers When Overriding Drug-Drug Interaction Alerts
Published: October 1st 2007 | Updated:

Trending on AJMC

Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care

Team-Based Precision Oncology: Advancing Value and Access in Cancer Care

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.